EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Leveraging Cancer Therapy Peptide Data: A Case Study on Machine Learning Application in Accelerating Cancer Research

Georgios Feretzakis, Athanasios Anastasiou, Stavros Pitoglou, Aikaterini Sakagianni, Zoi Rakopoulou, Konstantinos Kalodanis, Vasileios Kaldis, Evgenia Paxinou, Dimitris Kalles, Vassilios S Verykios

Studies in Health Technology and Informatics · 2024

DOI: 10.3233/shti241068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2024. Verfasst von Georgios Feretzakis und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Science and Technology, Hellenic Open University, Patras, Greece. Hauptthemen laut MEDLINE: Machine Learning, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study leverages the DCTPep database, a comprehensive repository of cancer therapy peptides, to explore the application of machine learning in accelerating cancer research. We applied Principal Component Analysis (PCA) and K-means clustering to categorize cancer therapy peptides based on their physicochemical properties. Our analysis identified three distinct clusters, each characterized by unique features such as sequence length, isoelectric point (pI), net charge, and mass. These findings provide valuable insights into the key properties that influence peptide efficacy, offering a foundation for the design of new therapeutic peptides. Future work will focus on experimental validation and the integration of additional data sources to refine the clustering and enhance the predictive power of the model, ultimately contributing to the development of more effective peptide-based cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningNeoplasmsHumansPeptidesPrincipal Component AnalysisDatabases, ProteinAntineoplastic Agents

Stichwörter der Autor:innen

Cancer therapy peptidesK-means clusteringMachine learningPCAPeptide design

Substanzen

PeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Science and Technology, Hellenic Open University, Patras, Greece.
  • Biomedical Engineering Laboratory, National Technical University of Athens, Athens, Greece.
  • Computer Solutions SA, Athens, Greece.
  • Sismanogleio General Hospital, Marousi, Greece.
  • Harokopio University of Athens, Kallithea, Greece.

Zitieren

APA

Feretzakis, G., Anastasiou, A., Pitoglou, S., Sakagianni, A., Rakopoulou, Z., Kalodanis, K., Kaldis, V., Paxinou, E., Kalles, D., & Verykios, V. S. (2024). Leveraging Cancer Therapy Peptide Data: A Case Study on Machine Learning Application in Accelerating Cancer Research. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti241068

Vancouver

Feretzakis G, Anastasiou A, Pitoglou S, Sakagianni A, Rakopoulou Z, Kalodanis K, et al. Leveraging Cancer Therapy Peptide Data: A Case Study on Machine Learning Application in Accelerating Cancer Research. Studies in Health Technology and Informatics. 2024. doi:10.3233/shti241068

BibTeX
@article{Feretzakis2024,
  author = {Feretzakis, Georgios and Anastasiou, Athanasios and Pitoglou, Stavros and Sakagianni, Aikaterini and Rakopoulou, Zoi and Kalodanis, Konstantinos and Kaldis, Vasileios and Paxinou, Evgenia and Kalles, Dimitris and Verykios, Vassilios S},
  title = {Leveraging Cancer Therapy Peptide Data: A Case Study on Machine Learning Application in Accelerating Cancer Research},
  journal = {Studies in Health Technology and Informatics},
  year = {2024},
  doi = {10.3233/shti241068}
}
Kostenlos starten →